![Qi Shuai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Qi Shuai
Direttore Finanziario/CFO presso
Brisco Biopharmaceutical (Hangzhou) Co., Ltd
Profilo
Qi Shuai is currently Chief Financial Officer at Bliss Biopharmaceutical (Hangzhou) Co., Ltd. since 2024.
Former positions include Chief Financial Officer & Co-Secretary at Alphamab Oncology from 2019 to 2020, Director at Deutsche Bank AG from 2016 to 2018, Vice President at Bain Capital Asia LLC (Shanghai) from 2015 to 2016, Executive Director at Morgan Stanley Asia Ltd. from 2011 to 2015, Associate at Credit Suisse (Hong Kong) Ltd. from 2010 to 2011, Associate at The Hong Kong & Shanghai Banking Corp.
Ltd. from 2008 to 2010, Research Scientist at Abbott Laboratories from 2002 to 2008.
Education includes a graduate degree from The Trustees of Columbia University in The City of New York in 2002, an undergraduate degree from the University of Science & Technology of China in 2000, and an MBA from The University of Chicago Booth School of Business in 2008.
Posizioni attive di Qi Shuai
| Società | Posizione | Inizio |
|---|---|---|
Brisco Biopharmaceutical (Hangzhou) Co., Ltd
 Brisco Biopharmaceutical (Hangzhou) Co., Ltd Pharmaceuticals: MajorHealth Technology Develops targeted and immunotherapeutic drugs for cancer | Direttore Finanziario/CFO | 02/09/2024 |
Precedenti posizioni note di Qi Shuai
| Società | Posizione | Fine |
|---|---|---|
| ALPHAMAB ONCOLOGY | Direttore Finanziario/CFO | 07/12/2020 |
| DEUTSCHE BANK AG | Direttore/Membro del Consiglio | 01/05/2018 |
Bain Capital Asia LLC (Shanghai)
 Bain Capital Asia LLC (Shanghai) Investment ManagersFinance Functions as an alternative investment manager | Corporate Officer/Principal | 01/06/2016 |
Morgan Stanley Asia Ltd.
 Morgan Stanley Asia Ltd. Investment Banks/BrokersFinance Provides brokerage services | Direttore/Membro del Consiglio | 01/07/2015 |
Credit Suisse (Hong Kong) Ltd.
 Credit Suisse (Hong Kong) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/05/2011 |
Formazione di Qi Shuai
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
96
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Deutsche Bank AG
 Deutsche Bank AG Investment Banks/BrokersFinance Provides investment and corporate banking & asset management services | Finance |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Credit Suisse (Hong Kong) Ltd.
Credit Suisse (Hong Kong) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Science & Technology of China
 University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bain Capital Asia LLC (Shanghai)
Bain Capital Asia LLC (Shanghai) Investment ManagersFinance Functions as an alternative investment manager | Finance |
Morgan Stanley Asia Ltd.
Morgan Stanley Asia Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hong Kong & Shanghai Banking Corp. Ltd.
 The Hong Kong & Shanghai Banking Corp. Ltd. Regional BanksFinance Provides banking and financial services | Finance |
Alphamab Oncology
 Alphamab Oncology BiotechnologyHealth Technology Operates as biopharmaceutical company which engages in development manufacturing and commercialization of therapeutics for cancer treatment | Health Technology |
Brisco Biopharmaceutical (Hangzhou) Co., Ltd
Brisco Biopharmaceutical (Hangzhou) Co., Ltd Pharmaceuticals: MajorHealth Technology Develops targeted and immunotherapeutic drugs for cancer | Health Technology |
